top banner image  

topleft corner image     top right corner image
 


bullet

JACC Homepage JACC Imaging Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

     top nav image

     

J Am Coll Cardiol Intv, 2009; 2:925-930, doi:10.1016/j.jcin.2009.08.009
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Ross, A. M.
Right arrow Articles by Van de Werf, F.
PubMed
Right arrow Articles by Ross, A. M.
Right arrow Articles by Van de Werf, F.
Related Collections
Right arrowRelated Article

Clinical Research

The Impact of Place of Enrollment and Delay to Reperfusion on 90-Day Post-Infarction Mortality in the ASSENT-4 PCI Trial

Assessment of the Safety and Efficacy of a New Treatment Strategy With Percutaneous Coronary Intervention

Allan M. Ross, MD*, Kurt Huber, MD{dagger}, Uwe Zeymer, MD{ddagger},*, Paul W. Armstrong, MD§, Christopher B. Granger, MD||, Patrick Goldstein, MD, Kris Bogaerts, MD#, Frans Van de Werf, MD**

* Department of Medicine, George Washington University, Washington, DC
{dagger} Third Department of Medicine, Cardiology and Emergency Medicine, Wihelminenhospital, Vienna, Austria
{ddagger} Herzzentrum, Ludwigshafen, Germany
§ Department of Cardiology, University of Alberta, Edmonton, Alberta, Canada
|| Duke Clinical Research Center, Durham, North Carolina
Hopital Lille, Lille, France
# Statistical Center, University Hospital Gasthuisberg, Leuven, Belgium
** Department of Cardiology, University Hospital Gasthuisberg, Leuven, Belgium

* Reprint requests and correspondence: Dr. Uwe Zeymer, Herzzentrum Ludwigshafen, Bremserstrasse 79, D-67063 Ludwigshafen, Germany (Email: Uwe.Zeymer{at}t-online.de).

Objectives: We have performed a retrospective analysis of the data stratified by time to treatment and by enrollment site: percutaneous coronary intervention hospitals (PCIH), nonpercutaneous coronary intervention hospitals (NoPCIH), or in a pre-hospital setting (PreH).

Background: The ASSENT-4 PCI (Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention) trial intended to test the hypothesis that in ST-segment elevation myocardial infarction (STEMI) patients an upfront fibrinolytic bolus before PCI ("facilitated PCI") compared with primary PCI would benefit STEMI patients facing a long pre-PCI delay.

Methods: Seven hundred forty-nine patients (45%) presented directly to PCIH, 578 (34%) presented to NoPCIH, and 334 (20%) were randomized and initially treated in the PreH setting.

Results: Patients in the PreH-facilitated group had the shortest delays (pain-to-fibrinolytic treatment 125 min) and the lowest 90-day mortality (3.1%). Among patients randomized to primary PCI, the shortest time from pain to first balloon was similarly in the PreH group (223 min). They had the lowest mortality of the primary PCI patient groups (4.1%). The highest mortality (8.4%) was in patients presenting to a PCIH and assigned to the facilitated strategy. Their pain-to-lysis time was 174 min and pain-to-PCI time 266 min (or 92 min after lysis).

Conclusions: Few patients fit the target population, long delays to PCI for whom facilitated PCI was designed. Patients treated early after pain onset in the PreH setting do well after a facilitated approach. Despite limitations of post hoc subgroup analysis, these observations suggest caution in extrapolating the results of the ASSENT-4 trial to the "real world" where many patients might have potentially short pain-to-fibrinolysis time but are facing a long transport time to primary PCI.

Key Words: facilitated PCI • reperfusion • STEMI

Abbreviations and Acronyms
  NoPCIH = nonpercutaneous coronary intervention hospitals
  PCI = percutaneous coronary intervention
  PCIH = percutaneous coronary intervention hospitals
  PreH = pre-hospital setting
  STEMI = ST-segment elevation myocardial infarction


Related Article

The Ideal Reperfusion Strategy for the ST-Segment Elevation Myocardial Infarction Patient With Expected Delay to Percutaneous Coronary Intervention: Paradise Lost or Paradise Renamed?
Timothy D. Henry and David M. Larson
J. Am. Coll. Cardiol. Intv. 2009 2: 931-933. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll Cardiol IntvHome page
T. D. Henry and D. M. Larson
The Ideal Reperfusion Strategy for the ST-Segment Elevation Myocardial Infarction Patient With Expected Delay to Percutaneous Coronary Intervention: Paradise Lost or Paradise Renamed?
J. Am. Coll. Cardiol. Intv., October 1, 2009; 2(10): 931 - 933.
[Full Text] [PDF]



 
   
 
home link current link search link archive link topics link cardiology careers link